Literature DB >> 4051547

Duodenal perforation associated with tolazoline.

R G Wilson, R J George, W J McCormick, P A Raine.   

Abstract

A neonate, managed with tolazoline for pulmonary hypertension after repair of a congenital diaphragmatic hernia, developed a duodenal perforation. The role of tolazoline in this condition is discussed, and possible measures to reduce its gastrointestinal side effects are proposed.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4051547      PMCID： PMC1777469          DOI： 10.1136/adc.60.9.878

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  An analysis of tolazoline therapy in the critically-ill neonate.

Authors:  D C Stevens; R L Schreiner; M J Bull; C Q Bryson; J A Lemons; E L Gresham; J L Grosfeld; T R Weber
Journal:  J Pediatr Surg       Date:  1980-12       Impact factor: 2.545

2.  Duodenal perforation with tolazoline therapy.

Authors:  M Matsuo; M Aida; T Yamada; H Takemine; C Tsugawa; K Kimura; Y Matsumoto
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

3.  Fatal gastrointestinal hemorrhage in a neonate treated with tolazoline.

Authors:  R G Dillard
Journal:  Clin Pediatr (Phila)       Date:  1982-12       Impact factor: 1.168

4.  Pulmonary vasodilator action of tolazoline.

Authors:  B W Goetzman; J M Milstein
Journal:  Pediatr Res       Date:  1979-08       Impact factor: 3.756

Review 5.  Pharmacology of tolazoline.

Authors:  R M Ward
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

6.  The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension.

Authors:  W H Drummond; G A Gregory; M A Heymann; R A Phibbs
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406
  6 in total
  1 in total

1.  Comparison of the haemodynamic effects of epoprostenol (prostacyclin) and tolazoline.

Authors:  A Bush; C M Busst; W B Knight; E A Shinebourne
Journal:  Br Heart J       Date:  1988-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.